Atlas Trials

Inventiva Pharma

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Inventiva Pharma

RecordFirmDate
Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus (NCT05232071)Inventiva Pharma2022-06-29
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) (NCT04849728)Inventiva Pharma2021-08-19
Multiple Ascending Dose Phase I Study in Order to Define Lanifibranor (IVA337) Supra-thjerapeutic Dose (NCT03866369)Inventiva Pharma2019-01-17
A Study in MPS VI to Assess Safety and Efficacy of Odiparcil (NCT03370653)Inventiva Pharma2017-12-30

Track Inventiva Pharma automatically

Every clearance here is in the API, with alerts when new ones post.